Upload
nguyenminh
View
215
Download
1
Embed Size (px)
CME QUESTIONS FOR JANUARY 2003 ISSUE OFTHE JOURNAL OF UROLOGY�
1. RANDOMIZED PROSPECTIVE EVALUATION OF EXTENDED VERSUS LIMITED LYMPH NODE DISSECTION INPATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER (vol. 169, pp. 145–148)
Compared to a limited dissection an extended pelvic lymphadenectomy does not increase the risk of:
a) lower extremity edemab) lymphocelec) impotenced) deep venous thrombosise) ureteral injury
2. INTRAVESICAL BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C FOR SUPERFICIAL BLADDERCANCER: A FORMAL META-ANALYSIS OF COMPARATIVE STUDIES ON RECURRENCE AND TOXICITY (vol.169, pp. 90–95)
As opposed to intravesical therapy of bladder cancer with mitomycin C, bacillus Calmette-Guerin:
a) has a lower tumor recurrence rateb) has no role in maintenance therapyc) has a lower toxicity rated) needs only 6 treatment cycles for superior effecte) is ineffective at a low dose
3. CONSERVATIVE ELECTIVE TREATMENT OF UPPER URINARY TRACT TUMORS: A MULTIVARIATEANALYSIS OF PROGNOSTIC FACTORS FOR RECURRENCE AND PROGRESSION (vol. 169, pp. 82–85)
Tumor excision instead of nephroureterectomy for upper urinary tract transitional cell carcinoma:
a) is best with renal pelvic tumorsb) is indicated after previous multi-recurrent bladder tumorsc) rarely needs close followupd) will not lead to tumor progressione) may be followed by bilateral recurrence
4. COMPLICATIONS OF RADICAL CYSTECTOMY FOR NONMUSCLE INVASIVE DISEASE: COMPARISON WITHMUSCLE INVASIVE DISEASE (vol. 169, pp. 101–104)
Radical cystectomy in patients with nonmuscle invasive disease as opposed to muscle invasive disease has:
a) a lower minor complication rateb) a lower major complication ratec) a lower blood transfusion rated) a shorter length of stay in the hospitale) the same incidence of ileus
5. THE EFFECT OF FINASTERIDE ON THE EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANDMICROVESSEL DENSITY: A POSSIBLE MECHANISM FOR THE DECREASED PROSTATIC BLEEDING INTREATED PATIENTS (vol. 169, pp. 20–23)
Vascular endothelial growth factor:
a) inhibits the action of finasterideb) stimulates 5�-reductasec) is a fundamental regulator of physiological and pathological angiogenesisd) inhibits angiogenesise) has decreased expression in areas of increased microvessel density
335